or
forgot password
  • cancer clinical trials in staten island, NY

  • Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Colorectal Cancer
    Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
    Richmond University Medical Center
    Staten Island, New York 10310-1699
    Lung Neoplasm, Carcinoma Non-small Cell Lung Cancer Stage IIIA, Carcinoma Non-small Cell Lung Cancer Stage IIIB, Carcinoma Non-small Cell Lung Cancer Stage IV
    Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer
    Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma
    Nalitt Institute for Cancer And Blood Related Diseases
    Staten Island, New York 10305
    Brain and Central Nervous System Tumors
    Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer
    R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence
    Staten Island Urologic Oncology
    Staten Island, New York 10305
    Prostate Cancer
    Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Esophageal Cancer, Gastric Cancer
    Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Colorectal Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Metastatic Cancer, Prostate Cancer
    Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy
    Staten Island Urological Research, P.C.
    Staten Island, New York 10304
    Metastatic Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Colorectal Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Staten Island University Hospital
    Staten Island, New York 10305
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer, Lymphedema, Perioperative/Postoperative Complications
    Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Staten Island University Hospital

    Trial Locations
    Staten Island University Hospital
    Richmond University Medical Center
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Staten Island University Hospital
    Staten Island, New York 10305
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Staten Island Urological Research, PC
    Staten Island, New York 10304
    Prostate Cancer
    CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
    Richmond University Medical Center
    Staten Island, New York 10310-1699
    NSCLC
    Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer
    Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
    Richmond University Medical Center
    Staten Island, New York 10310-1699
    Venous Thrombosis
    Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV Breast Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
    Richmond University Medical Center
    Staten Island, New York 10310-1699
    Pancreatic Cancer
    Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Male Breast Cancer, Recurrent Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer
    Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed By Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
    Staten Island University Hospital
    Staten Island, New York 10305
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Male Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Distal Urethral Cancer, Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter, Proximal Urethral Cancer, Recurrent Bladder Cancer, Recurrent Prostate Cancer, Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter, Recurrent Urethral Cancer, Stage IV Bladder Cancer, Stage IV Prostate Cancer, Transitional Cell Carcinoma of the Bladder, Urethral Cancer Associated With Invasive Bladder Cancer
    S0819: Carboplatin/Paclitaxel With or Without Bevacizumab and/or Cetuximab in Stage IV or Recurrent Non-Small Cell Lung Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Lung Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Ovarian Cancer, Sarcoma
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer, Cardiac Toxicity
    Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Colorectal Cancer
    Paclitaxel and Carboplatin With or Without Bevacizumab in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
    Staten Island University Hospital
    Staten Island, New York 10305
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    Staten Island Urological Research, PC
    Staten Island, New York 10304
    Prostatic Neoplasms
    A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Staten Island Urological Research, PC
    Staten Island, New York 10304
    Advanced Prostate Cancer, Prostatic Neoplasms
    A Study to Test the Ability of and Safety of GSK2110183 in Treating Langerhans Cell Histiocytosis
    Staten Island University Hospital
    Staten Island, New York 10305
    Langerhans Cell Histiocytosis
    Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
    Staten Island Urological Research, PC
    Staten Island, New York 10304
    Prostate Cancer
    Efficacy Study of a Urine DEK ELISA for Diagnosis of Bladder Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Hematuria, Dysuria, Bladder Cancer
    Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
    St. Vincent's Medical Center of Richmond
    Staten Island, New York 10310
    Chronic Myeloproliferative Disorders, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer
    Biological Therapy in Treating Patients With Primary or Advanced Glioma
    Staten Island University Hospital
    Staten Island, New York 10305
    Brain and Central Nervous System Tumors
    Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer
    Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer
    Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
    Nalitt Cancer Institute at Staten Island University Hospital
    Staten Island, New York 10305
    Breast Cancer, Osteoporosis
    A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
    Private Practice
    Staten Island, New York 10305
    Prostatic Intraepithelial Neoplasia
    A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes
    Staten Island Unversity Hospital
    Staten Island, New York 10305
    Myelodysplastic Syndromes
    The Effect of Zoledronic Acid on Bone Loss in Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
    Staten Island Urological Research, PC
    Staten Island, New York 10304
    Prostate Cancer
    A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Staten Island Medical Group
    Staten Island, New York 10301
    Lung Cancer, Non-small-cell Lung Carcinoma
    The Plenaxis® Experience Study
    Staten Island Urological Research, PC
    Staten Island, New York 10304
    Prostate Cancer
    Study of AS1404 With Docetaxel in Patients With Hormone Refractory Metastatic Prostate Cancer
    Staten Island Urological Research
    Staten Island, New York 10304
    Prostate Cancer
    Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy
    Staten Island Urological Research , PC
    Staten Island, New York 10304
    Prostate Cancer, Osteoporosis, Fractures
    Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
    St. Vincent Catholic Medical Center of New York
    Staten Island, New York 10310
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Neoplasms
    Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)
    Richmond University Medical Center
    Staten Island, New York 10310-1699
    Prostate Cancer
    Assessment and Tracking of Long-term Alefacept Safety
    Josiane Lederman, MD, PC
    Staten Island, New York 10314
    Psoriasis
    Study of Apixaban for the Prevention of Thrombosis-related Events in Patients With Acute Medical Illness
    Staten Island University Hospital
    Staten Island, New York 10305
    Venous Thrombosis, Pulmonary Embolism
    A Phase 1 Study Investigating the Combination of RAD001, Cetuximab and Irinotecan as Second-line Therapy After FOLFOX (or XELOX) Plus Bevacizumab in Patients With Metastatic Colorectal Cancer
    Richmond University Medical Center
    Staten Island, New York 10310-1699
    Colorectal Cancer, Colorectal Carcinoma, Colorectal Tumors, Neoplasms, Colorectal